azacitidine has been researched along with Thalassemias in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (80.65) | 18.7374 |
| 1990's | 3 (9.68) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Datta, S | 1 |
| Lal, A; Vichinsky, E | 1 |
| Atweh, GF; Fathallah, H; Sutton, M | 1 |
| Anagnou, NP; DeSimone, J; Humphries, RK; Keller, GH; Keller, P; Ley, TJ; Nienhuis, AW; Turner, PH; Young, NS | 1 |
| Benz, EJ | 2 |
| Kolata, G | 1 |
| Orkin, SH | 1 |
| Anagnou, NP; DeSimone, J; Heller, P; Ley, TJ; Nienhuis, AW; Young, NS | 1 |
| Bodmer, WF; Clegg, JB; Weatherall, DJ | 1 |
| DeSimone, J; Heller, P; Ley, TJ; Nienhuis, AW; Noguchi, CT; Schechter, AN; Turner, PH | 1 |
| Kuratowska, Z | 1 |
| Cypress, GC; Nalbandian, RM | 1 |
| Adamson, JW | 1 |
| DeSimone, J; Heller, P | 1 |
| Steinberg, MH | 1 |
| Craig, JE; Rochette, J; Thein, SL | 1 |
| Nienhuis, AW; Stamatoyannopoulos, JA | 1 |
| Fujita, S | 1 |
| Dover, G; Humphries, RK; Ley, TJ; Nienhuis, AW; Young, NS | 1 |
| Boyer, SH; Charache, S; Dover, GJ; Nora, R | 1 |
| Anderson, WF; Berg, P; Eglitis, M; Goldberg, S; Humphries, RK; Kantoff, P | 1 |
| Karlsson, S; Nienhuis, AW | 1 |
| Platt, OS | 1 |
| Dunbar, C; Kan, YW; Nienhuis, A; Travis, W | 1 |
| Rokicka-Piotrowicz, M | 1 |
| Ley, TJ; Macher, AM; Nienhuis, AW; Sands, JM | 1 |
| Jones, PA | 1 |
| Charache, S; Dover, G; Humphries, RK; Ley, T; Moore, JG; Nienhuis, AW; Young, NS | 1 |
| Ley, TJ; Nienhuis, AW | 1 |
10 review(s) available for azacitidine and Thalassemias
| Article | Year |
|---|---|
The role of fetal hemoglobin-enhancing agents in thalassemia.
Topics: Azacitidine; Decitabine; Fetal Hemoglobin; Humans; Thalassemia; Treatment Outcome | 2004 |
Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
Topics: Anemia, Sickle Cell; Animals; Azacitidine; Combined Modality Therapy; Drug Approval; Drug Evaluation; Drug Evaluation, Preclinical; Erythropoiesis; Fetal Hemoglobin; Gene Expression; Gene Expression Regulation; Globins; Humans; Hydroxyurea; Iron; K562 Cells; Models, Animal; Papio; Thalassemia; Transfusion Reaction; United States; United States Food and Drug Administration | 2005 |
5-Azacytidine and fetal hemoglobin.
Topics: Adult; Anemia, Sickle Cell; Animals; Azacitidine; Carcinogens; Disease Models, Animal; DNA; Fetal Hemoglobin; Gene Expression Regulation; Humans; Male; Methylation; Middle Aged; Papio; Thalassemia | 1984 |
Review: the sickle hemoglobinopathies--genetic analyses of common phenocopies and new molecular approaches to treatment.
Topics: Anemia, Sickle Cell; Animals; Azacitidine; Fetal Hemoglobin; Gene Expression Regulation; Genotype; Globins; Hemoglobin A; Hemoglobin A2; Hemoglobin SC Disease; Hemoglobin, Sickle; Humans; Phenotype; Sickle Cell Trait; Thalassemia | 1984 |
Fetal hemoglobin levels in adults.
Topics: Adult; Azacitidine; Base Sequence; Butyrates; Butyric Acid; Fetal Hemoglobin; Gene Expression Regulation; Genetic Therapy; Globins; Humans; Hydroxyurea; Molecular Sequence Data; Sequence Deletion; Thalassemia | 1994 |
Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Topics: Anemia, Sickle Cell; Animals; Azacitidine; Erythropoietin; Fetal Hemoglobin; Gene Expression Regulation; Hemoglobinopathies; Humans; Hydroxyurea; Thalassemia | 1992 |
Developmental regulation of human globin genes.
Topics: Azacitidine; Chromatin; Chromosome Deletion; Chromosomes, Human, 16-18; Chromosomes, Human, 6-12 and X; Enhancer Elements, Genetic; Fetal Hemoglobin; Gene Expression Regulation; Genes; Globins; Hemoglobins; Humans; Methylation; Mutation; Poly A; Promoter Regions, Genetic; Protein Biosynthesis; Repetitive Sequences, Nucleic Acid; RNA Caps; RNA Processing, Post-Transcriptional; RNA, Messenger; Thalassemia; Transcription Factors | 1985 |
[Fetal hemoglobin].
Topics: Amino Acid Sequence; Amino Acids; Anemia, Sickle Cell; Azacitidine; Fetal Blood; Fetal Hemoglobin; Humans; Molecular Sequence Data; Stimulation, Chemical; Thalassemia | 1989 |
Altering gene expression with 5-azacytidine.
Topics: Anemia, Sickle Cell; Animals; Azacitidine; Cell Differentiation; Cell Line; DNA; Embryo, Mammalian; Embryo, Nonmammalian; Fetal Hemoglobin; Gene Expression Regulation; Genes; Genes, Regulator; Methylation; Mutation; Neoplasms; Thalassemia; Thymidine Kinase | 1985 |
Induction of hemoglobin F synthesis in patients with beta thalassemia.
Topics: Animals; Azacitidine; DNA; Erythroblasts; Female; Fetal Hemoglobin; Gene Expression Regulation; Globins; Humans; Hydroxyurea; Methylation; Papio; Thalassemia | 1985 |
2 trial(s) available for azacitidine and Thalassemias
| Article | Year |
|---|---|
Molecular genetics of the sickling syndromes: evolution of new strategies for improved diagnosis.
Topics: Anemia, Sickle Cell; Azacitidine; Base Composition; Chromosome Mapping; Clinical Trials as Topic; DNA Restriction Enzymes; DNA, Recombinant; Gene Expression Regulation; Genes; Globins; Hemoglobin SC Disease; Humans; Prenatal Diagnosis; Thalassemia | 1984 |
Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
Topics: Anemia, Sickle Cell; Animals; Azacitidine; Bone Marrow; Cells, Cultured; Clinical Trials as Topic; Erythropoiesis; Fetal Hemoglobin; Humans; Hydroxyurea; Reticulocytes; Thalassemia | 1985 |
19 other study(ies) available for azacitidine and Thalassemias
| Article | Year |
|---|---|
Treatment of thalassoemia--the current scenario.
Topics: Azacitidine; Bone Marrow Transplantation; Deferiprone; Fetal Hemoglobin; Genetic Therapy; Humans; Hydroxyurea; Iron Chelating Agents; Pyridones; Thalassemia | 2002 |
5-azacytidine selectively increases gamma-globin synthesis in a patient with beta+ thalassemia.
Topics: Adult; Azacitidine; DNA; Erythropoiesis; Gene Expression Regulation; Globins; Hemoglobins; Humans; Male; Methylation; RNA, Messenger; Stimulation, Chemical; Thalassemia | 1982 |
Clinical management of gene expression.
Topics: Azacitidine; DNA; Fetal Hemoglobin; Gene Expression Regulation; Globins; Humans; Methylation; Thalassemia | 1982 |
Fetal hemoglobin genes turned on in adults.
Topics: Adult; Anemia, Sickle Cell; Azacitidine; Fetal Hemoglobin; Hemoglobin, Sickle; Humans; Male; Thalassemia | 1982 |
5-azacytidine for beta-thalassaemia?
Topics: Animals; Azacitidine; Fetal Hemoglobin; Gene Expression Regulation; Humans; Thalassemia | 1983 |
Controlling the fetal globin switch in man.
Topics: Anemia, Sickle Cell; Animals; Azacitidine; Fetal Hemoglobin; Gene Expression Regulation; Humans; Papio; Thalassemia | 1983 |
5-azacytidine for beta thalassaemia?
Topics: Azacitidine; Ethics, Medical; Fetal Hemoglobin; Humans; Risk Assessment; Thalassemia; Therapeutic Human Experimentation | 1983 |
5-azacytidine for beta-thalassemia?
Topics: Azacitidine; Child; Ethics, Medical; Human Experimentation; Humans; Thalassemia | 1983 |
5-Azacytidine increases gamma-globin synthesis and reduces the proportion of dense cells in patients with sickle cell anemia.
Topics: Adult; Anemia, Sickle Cell; Azacitidine; Bone Marrow Cells; DNA; Erythrocytes; Fetal Hemoglobin; Globins; Humans; Male; Methylation; Middle Aged; RNA, Messenger; Thalassemia | 1983 |
[Pharmacological correction of genetic defects - azacytidine in the treatment of thalassemia].
Topics: Azacitidine; Fetal Hemoglobin; Gene Expression Regulation; Humans; Thalassemia | 1983 |
Gene switching -- a new therapeutic epoch: discussion paper.
Topics: Anemia, Sickle Cell; Azacitidine; Female; Fetal Blood; Fetal Hemoglobin; Gene Expression Regulation; Genes; Hemoglobins; Humans; Operon; Pregnancy; Thalassemia | 1984 |
Hemoglobin--from F to A, and back.
Topics: Anemia, Sickle Cell; Azacitidine; DNA; Fetal Hemoglobin; Humans; Hydroxyurea; Methylation; Thalassemia | 1984 |
[Congenital hemoglobin abnormalities--thalassemia syndrome].
Topics: Animals; Azacitidine; Blood Transfusion; Hemoglobins; Humans; Thalassemia | 1991 |
Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta-thalassemia.
Topics: Azacitidine; Fetal Hemoglobin; Globins; Humans; Hydroxyurea; Iron; Kinetics; RNA; Thalassemia; Time Factors | 1985 |
Attempts at gene therapy in beta-thalassemic mice.
Topics: Animals; Azacitidine; Base Sequence; DNA, Recombinant; DNA, Viral; Genetic Engineering; Genetic Vectors; Globins; Mice; Mice, Mutant Strains; Microinjections; Pedigree; Retroviridae; Thalassemia | 1985 |
Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
Topics: Anemia, Sickle Cell; Azacitidine; Cytarabine; Fetal Hemoglobin; Humans; Hydroxyurea; Kinetics; Thalassemia | 1985 |
5-Azacytidine treatment in a beta (0)-thalassaemic patient unable to be transfused due to multiple alloantibodies.
Topics: Adult; Azacitidine; Humans; Isoantibodies; Male; Thalassemia | 1989 |
Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalassemia. Case report and review of the literature.
Topics: Adult; Azacitidine; Chronic Disease; Diagnosis, Differential; Entomophthora; Hematopoiesis; Humans; Immune Tolerance; Male; Mucormycosis; Mycoses; Splenectomy; Thalassemia | 1985 |
5-Azacytidine acts directly on both erythroid precursors and progenitors to increase production of fetal hemoglobin.
Topics: Adult; Anemia, Sickle Cell; Azacitidine; Erythrocytes; Erythropoiesis; Fetal Hemoglobin; Hematopoietic Stem Cells; Humans; Middle Aged; RNA, Messenger; Thalassemia | 1985 |